https://www.selleckchem.com/products/wh-4-023.html
5% after 1year (8/9) and 71.4% after 3years (5/7). The most effective first-line therapy and retreatment option remains rituximab. The effectiveness of other treatment options like splenectomy or different immunotherapeutic approaches requires confirmation in larger-scale studies. The most effective first-line therapy and retreatment option remains rituximab. The effectiveness of other treatment options like splenectomy or different immunotherapeutic approaches requires confirmation in larger-scale studies.Allergic contact dermatitis (
Like
Comment
Share
